Cancer Progression Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis

Disease progression and treatment with hydroxychloroquine and azithromycin were associated with increased all-cause 30-day mortality in patients with cancer compared to patients either in remission or with no evidence of disease, according to data presented during a 2020 ASCO Virtual Scientific Program press briefing.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news